Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial

Por Wade, Alan G, Farmer, Mildred, Harari, Gil, Fund, Naama, Laudon, Moshe, Nir, Tali, Frydman-Marom, Anat, Zisapel, Nava
Publicado em 2014

Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial

Por Zelber-Sagi, Shira, Buch, Assaf, Yeshua, Hanny, Vaisman, Nahum, Webb, Muriel, Harari, Gil, Kis, Ofer, Fliss-Isakov, Naomi, Izkhakov, Elena, Halpern, Zamir, Santo, Erwin, Oren, Ran, Shibolet, Oren
Publicado em 2014

RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

Por Golan, Talia, Khvalevsky, Elina Zorde, Hubert, Ayala, Gabai, Rachel Malka, Hen, Naama, Segal, Amiel, Domb, Abraham, Harari, Gil, David, Eliel Ben, Raskin, Stephen, Goldes, Yuri, Goldin, Eran, Eliakim, Rami, Lahav, Maor, Kopleman, Yael, Dancour, Alain, Shemi, Amotz, Galun, Eithan
Publicado no Oncotarget (2015)